Clinical Trials
2 trialsNCT05255133 2025-01-06
Liquid-NET
Universiteit Antwerpen
Phase NA Completed
NCT05268952 2022-03-07
A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)
University Hospital, Antwerp
Phase NA Unknown